BPC-157 (Body Protection Compound-157) is a partial sequence of a gastric protein studied extensively in preclinical models. Irish Peptide Research supplies BPC-157 as a research compound in Ireland for laboratory and in vitro research use only.
The compound has been investigated in vitro and in animal models for its apparent effects on angiogenesis, nitric oxide signaling, and growth factor expression related to tissue repair.
Mechanism of Action
Studies have investigated how BPC-157 may interact with the nitric oxide system, vascular endothelial growth factor (VEGF), and fibroblast activity. In vitro models suggest potential modulation of these pathways, though mechanism remains under investigation.
Preclinical Research Context
Laboratory studies have examined BPC-157 in models of tendon, muscle, and gastrointestinal tissue. This research is for laboratory and in vitro research use only and is not intended for human use.
Sources: Sikiric et al 2010